MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.34
+0.08 (+5.93%)
Open$1.28
Previous Close$1.27
Day High$1.36
Day Low$1.27
52W High$3.95
52W Low$1.23
Volume—
Avg Volume211.3K
Market Cap52.29M
P/E Ratio—
EPS$-2.36
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,183.6% upside
Current
$1.34
$1.34
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.81M | 23.60M | 24.43M |
| Net Income | -93,445,173 | -74,038,784 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -96,551,033 | -80,749,609 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |